Olive oil as a shield? trial tests whether a daily spoonful cuts heart risks in HIV

NCT ID NCT07761819

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial asks whether taking 50 mL of extra virgin olive oil every day can reduce the chance of heart attacks, strokes, and related deaths in people living with HIV. About 1,300 adults aged 50–75 with well-controlled HIV and at least one heart risk factor will be randomly assigned to add olive oil to their diet or to continue their usual eating habits. Over five years, researchers will compare how many in each group experience a major cardiovascular event, and also track changes in weight, blood pressure, and other health markers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Extra virgin olive oil (EVOO) taken daily as a dietary supplement
What this could lead to
If it works, daily olive oil could become a simple, low-cost way to lower heart and stroke risk in people living with HIV.
What could go wrong
This is an open-label trial, so results may be influenced by expectations. The effect may be modest, and daily intake of 50 mL adds calories, which could affect weight.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Universitario Costa del Sol

    Marbella, Málaga, 29603, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.